METROPOLIS
Metropolis
Live Price
₹559.90
+14.25+2.61%
Conviction Scorecard
AI Momentum
33%Technical Rating
56%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for METROPOLIS will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Balanced market signals for METROPOLIS. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Metropolis
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services. It also provides diagnostic services for oncology, chronic and infectious diseases, gastroenterology, neurology, nephrology, and women and child health, as well as various health checkup and laboratory services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, mobile app, website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.
Frequently asked questions
As of the latest market session, Metropolis (METROPOLIS) is trading at ₹559.9, representing a move of 2.61% from the previous close.
Metropolis is listed and traded under the ticker symbol METROPOLIS on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Metropolis's stock price moved by 2.61%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 33% bullish probability for METROPOLIS stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Metropolis shares reached a high of ₹609.05 and hit a low of ₹412.25.
METROPOLIS exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 1,62,721 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Metropolis has a market capitalization of ₹11615.88 Cr, designating its size class inside the Healthcare sector.
Metropolis has a current dividend yield of 37.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Metropolis's trailing Price-to-Earnings (P/E) ratio is 57.66. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Metropolis (METROPOLIS) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Metropolis's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore METROPOLIS's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for METROPOLIS are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Metropolis operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.